FDA applicant
Wallac OY
FDA records 24 decisions for Wallac OY (Turku, FI) from 1992 to 2014: 22 510(k) clearances and 2 De Novo grants. Most are in product codes JLX (Radioimmunoassay, 17-Hydroxyprogesterone) and CGZ (Electrode, Ion-Specific, Chloride). Its devices cite 12 predicates, 5 of them its own earlier devices. 7 recalls are linked to its devices.
FDA’s records also spell it “Wallac, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Wallac OY’s devices, and how often a recall has named them.
FDA decisions per year
1in 2014
2026 so far, outlined.
Recalls per year
1in 2017
Class I Class II/III not classified
Planning a device like Wallac OY’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Wallac”
FDA records each applicant name separately; these may or may not be the same firm.